CABA
Price
$1.99
Change
+$0.19 (+10.56%)
Updated
Jun 13 closing price
Capitalization
178.99M
54 days until earnings call
CRSP
Price
$41.36
Change
+$0.08 (+0.19%)
Updated
Jun 13 closing price
Capitalization
3.57B
58 days until earnings call
Interact to see
Advertisement

CABA vs CRSP

Header iconCABA vs CRSP Comparison
Open Charts CABA vs CRSPBanner chart's image
Cabaletta Bio
Price$1.99
Change+$0.19 (+10.56%)
Volume$4.57M
Capitalization178.99M
CRISPR Therapeutics AG
Price$41.36
Change+$0.08 (+0.19%)
Volume$2.02M
Capitalization3.57B
CABA vs CRSP Comparison Chart
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. CRSP commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and CRSP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (CABA: $1.99 vs. CRSP: $41.36)
Brand notoriety: CABA and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 226% vs. CRSP: 93%
Market capitalization -- CABA: $178.99M vs. CRSP: $3.57B
CABA [@Biotechnology] is valued at $178.99M. CRSP’s [@Biotechnology] market capitalization is $3.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, CABA is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 6 TA indicator(s) are bullish while CRSP’s TA Score has 6 bullish TA indicator(s).

  • CABA’s TA Score: 6 bullish, 4 bearish.
  • CRSP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CABA and CRSP are a good buy in the short-term.

Price Growth

CABA (@Biotechnology) experienced а -19.76% price change this week, while CRSP (@Biotechnology) price change was -1.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

CABA is expected to report earnings on Aug 07, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.57B) has a higher market cap than CABA($179M). CRSP YTD gains are higher at: 5.081 vs. CABA (-12.335). CABA has higher annual earnings (EBITDA): -112.92M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. CABA (183M). CABA has less debt than CRSP: CABA (15.2M) vs CRSP (219M). CRSP has higher revenues than CABA: CRSP (35M) vs CABA (0).
CABACRSPCABA / CRSP
Capitalization179M3.57B5%
EBITDA-112.92M-455.24M25%
Gain YTD-12.3355.081-243%
P/E RatioN/AN/A-
Revenue035M-
Total Cash183M1.86B10%
Total Debt15.2M219M7%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABACRSP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEUIX26.68N/A
N/A
SEI Large Cap Value I (SIMT)
HQIVX21.35N/A
N/A
Hartford Equity Income R6
ASQGX15.94N/A
N/A
American Century Small Company R5
GLEAX14.03N/A
N/A
GS Energy Infrastructure Fd A Shares
AEPIX25.26N/A
N/A
Allspring Managed Acct Corebuilder EPI

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+10.56%
KYTX - CABA
46%
Loosely correlated
-6.94%
IPSC - CABA
44%
Loosely correlated
-4.10%
ARCT - CABA
44%
Loosely correlated
-2.06%
CRSP - CABA
42%
Loosely correlated
+0.19%
AUTL - CABA
41%
Loosely correlated
-1.40%
More